XBiotech and BioBridge Global Collaborate on FDA Program to Develop Potential COVID-19 Treatment Based on Natural Antibodies from Recovered Patients
AUSTIN, Texas, April 03, 2020 (GLOBE NEWSWIRE) — XBiotech Inc. (NASDAQ: XBIT) and BioBridge Global today announced their collaboration to […]